Johnson & Johnson (NYSE:JNJ) reported on Monday that its board of directors approved a common stock cash dividend of USD0.95 per share for the third quarter of 2019,the company .
With an ex-dividend date of 26 August 2019, the dividend will be paid on 10 September 2019 to shareholders of record at the close of business on 27 August 2019.
Johnson & Johnson together with its subsidiaries, researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was incorporated in 1887 and is based in New Brunswick, New Jersey, USA.
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement